LSE:GSKPharmaceuticals
Does GSK’s Recent 8% Rise Signal More Upside After Pharma Tariff Headlines?
Thinking about what to do with GSK stock right now? You’re not alone. Whether you’re holding, buying, or just watching from the sidelines, the debate around GSK has definitely heated up. The last year has seen some pretty notable moves in its price. If you’re tracking those short-term swings or watching how GSK’s long-term story unfolds, you’ll spot signs that risk perceptions are shifting alongside the company’s growth potential.
Let’s break it down: Over the last month, GSK shares are up...